Common use in the general population of sexual enrichment AIDS and drugs to enhance sexual experience

Sexually Transmitted Diseases
Betsy FoxmanKing K Holmes

Abstract

We describe the prevalence of ever and current use of sexual enrichment aids and of using drugs to enhance the sexual experience, and correlates of that usage. Participants in a random-digit dial survey conducted in the Seattle area between 2003 and 2004 among residents age 18 to 39 years of age with fluency in the English language. Use of sexual enrichment aids and drugs to enhance sexual experience during a typical 4-week period were reported by 27% and 13%, respectively, of participants. Among those reporting using a drug to enhance their sexual experience, the most commonly used drugs were alcohol (83.7%), marijuana (34.7%), ecstasy or "sextasy" (ecstasy combined with sildenafil) (8.2%), and sildenafil (7.5%). Persons reporting use of sexual enrichment aids and drugs to enhance sexual experience were more likely to engage in sexual behaviors associated with a higher risk of acquiring and transmitting a sexually transmitted infection (STI),such as having nonmonogamous partnerships and multiple partners in the previous 12 months and sexual repertoire. Whether use of sexual enrichment aids and drugs to enhance sexual experience is causally associated with STI risk or merely an additional marker of high-risk behavior or sensati...Continue Reading

References

May 20, 1998·Sexually Transmitted Diseases·B FoxmanK K Holmes
May 10, 2002·The Journal of Infectious Diseases·Jeanne M MarrazzoSharon L Hillier
Jan 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helena A Kwakwa, M W Ghobrial
Jun 10, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Priscilla Lee ChuSandra Schwarcz
Jun 18, 2003·Journal of Substance Abuse Treatment·Carol J BoydHannah d'Arcy
Mar 11, 2004·Journal of General Internal Medicine·Rachel L JohnsonLisa A Cooper
May 7, 2004·American Journal of Epidemiology·Grant ColfaxUNKNOWN EXPLORE Study Team

❮ Previous
Next ❯

Citations

Jan 5, 2011·Archives of Sexual Behavior·Joshua G RosenbergerMichael Reece
Nov 23, 2007·Journal of Addictive Diseases·Keith J HorvathAnn Cotton
Jan 9, 2016·AIDS Patient Care and STDs·Hong-Van TieuUNKNOWN NYC M2M Study Team
May 21, 2009·The Journal of Sexual Medicine·Michael ReeceJ Dennis Fortenberry
Jun 22, 2010·The Journal of Sexual Medicine·Michael ReeceDavid S Novak
Feb 18, 2010·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Devon J HenselDonald P Orr
Apr 27, 2013·BMC Infectious Diseases·Ben B HuiDavid G Regan
Apr 21, 2007·Journal of Psychopharmacology·H R SumnallJ C Cole
Feb 10, 2012·Journal of Pharmacy Practice·Keith I Yoshizuka, Paul J Perry
Mar 7, 2009·Sexually Transmitted Diseases·Irene A DohertyAdaora A Adimora
Feb 9, 2011·Sexually Transmitted Diseases·Kimberly A PowersWilliam C Miller
Aug 19, 2007·Sexually Transmitted Diseases·David FineUNKNOWN Region X Infertility Prevention Project
Sep 25, 2008·Sexually Transmitted Diseases·Jami S Leichliter
Oct 6, 2009·Sexually Transmitted Diseases·K M O'RourkeJane S Hocking
Feb 11, 2011·Current Infectious Disease Reports·Sevgi O Aral
Apr 11, 2014·Archives of Sexual Behavior·Jennifer NieldKate L Lapane
Aug 19, 2008·Journal of Public Health Management and Practice : JPHMP·Ping DuF Bruce Coles
Mar 17, 2012·Sexually Transmitted Diseases·Pamela Ann MatsonJonathan Mark Ellen
Sep 24, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Adaora A AdimoraUNKNOWN HPTN 064 Protocol Team
Nov 9, 2011·Anthropology & Medicine·Mark M MacaudaClaudia C Santelices
Sep 25, 2012·Sexually Transmitted Diseases·Mary A OttJ Dennis Fortenberry
Jul 27, 2017·Scientific Reports·David JuherCaterina Scoglio
Apr 17, 2012·Sexually Transmitted Diseases·Mirjam KretzschmarStuart Berman
Sep 17, 2013·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·C BuonoL A Braunstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.